FDA Authorizes First At-Home, Non-Prescription Molecular COVID-19 Test

By Kelly Lienhard / March 5, 2021 at 10:00 PM
FDA on Friday (March 5) granted emergency use authorization to the first non-prescription molecular COVID-19 test for at-home use. The test’s manufacturer, Cue Health, said it expects to manufacture more than 100,000 test kits per day by this summer. The Cue COVID-19 Test for Home and Over The Counter Use works by analyzing a self-taken swab for nucleic acid from SARS-CoV-2. Once the swab is placed in a test cartridge, the cartridge reader runs the tests and sends the results...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.